= ltem3of29 <q Se a) A fcc] Pr
Question la: 1174 . 4 Mark Previous Next Full Screen 2 Lab a Notes Calculator _ Reverse Color
A physician research group is evaluating the efficacy of a new lipid-lowering drug, Superstatin,
which is being marketed directly to consumers as a groundbreaking new therapy to prevent
heart attacks. The drug manufacturer claims that the drug is more effective than existing
hypolipidemic agents for primary prevention of myocardial infarction. Results of a 5-year,
randomized, double-blinded, controlled study to evaluate the efficacy of Superstatin are shown
below.
Number of patients treated with Number of patients treated with
Superstatin control medication
Myocardial
. ; 10 25
infarction
No myocardial
990 975

infarction

Compared to the control medication, how many patients need to be treated with Superstatin to
prevent one additional myocardial infarction?

GA &

Text Zoom â€”_ Settings

@ As2 Activate Windows

Block Time Elapsed: 00:00:14 %

Tutor

Feedback

()

Suspend End Block

